Cue Biopharma Inc (CUE)
2.07
-0.11
(-5.05%)
USD |
NASDAQ |
May 08, 11:03
Cue Biopharma Price: 2.07 for May 8, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 07, 2024 | 2.09 | 2.20 | 2.07 | 2.18 | 217527.0 |
| May 06, 2024 | 2.07 | 2.26 | 2.05 | 2.08 | 319295.0 |
| May 03, 2024 | 1.90 | 2.19 | 1.87 | 2.13 | 663094.0 |
| May 02, 2024 | 1.91 | 1.936 | 1.76 | 1.88 | 226091.0 |
| May 01, 2024 | 1.92 | 1.986 | 1.60 | 1.905 | 622040.0 |
| Apr 30, 2024 | 1.40 | 1.98 | 1.37 | 1.90 | 1.261M |
| Apr 29, 2024 | 1.39 | 1.48 | 1.38 | 1.42 | 155923.0 |
| Apr 26, 2024 | 1.40 | 1.44 | 1.315 | 1.365 | 264389.0 |
| Apr 25, 2024 | 1.42 | 1.42 | 1.303 | 1.41 | 169155.0 |
| Apr 24, 2024 | 1.53 | 1.58 | 1.38 | 1.42 | 319520.0 |
| Apr 23, 2024 | 1.56 | 1.60 | 1.49 | 1.50 | 161467.0 |
| Apr 22, 2024 | 1.55 | 1.60 | 1.49 | 1.57 | 181253.0 |
| Apr 19, 2024 | 1.56 | 1.605 | 1.52 | 1.56 | 169010.0 |
| Apr 18, 2024 | 1.64 | 1.65 | 1.56 | 1.58 | 169330.0 |
| Apr 17, 2024 | 1.50 | 1.64 | 1.50 | 1.63 | 315904.0 |
| Apr 16, 2024 | 1.57 | 1.67 | 1.47 | 1.495 | 286850.0 |
| Apr 15, 2024 | 1.77 | 1.77 | 1.57 | 1.595 | 239114.0 |
| Apr 12, 2024 | 1.76 | 1.76 | 1.65 | 1.75 | 343510.0 |
| Apr 11, 2024 | 1.81 | 1.85 | 1.66 | 1.76 | 429905.0 |
| Apr 10, 2024 | 1.87 | 1.90 | 1.72 | 1.775 | 244454.0 |
| Apr 09, 2024 | 1.94 | 1.96 | 1.81 | 1.90 | 537938.0 |
| Apr 08, 2024 | 1.90 | 2.08 | 1.85 | 2.04 | 464499.0 |
| Apr 05, 2024 | 1.80 | 1.85 | 1.75 | 1.85 | 220401.0 |
| Apr 04, 2024 | 1.83 | 1.87 | 1.74 | 1.78 | 234025.0 |
| Apr 03, 2024 | 1.80 | 1.837 | 1.735 | 1.77 | 277037.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.365
Minimum
Apr 26 2024
30.73
Maximum
Jun 02 2020
9.007
Average
7.95
Median
Jun 25 2019
Price Benchmarks
| Precision BioSciences Inc | 10.96 |
| NovaBay Pharmaceuticals Inc | 0.084 |
| Palatin Technologies Inc | 2.09 |
| iBio Inc | 1.96 |
| Theriva Biologics Inc | 0.41 |
Price Related Metrics
| PS Ratio | 17.25 |
| Price to Book Value | 2.715 |
| Earnings Yield | -53.62% |
| Market Cap | 100.69M |